Sunday, July 04, 2004 10:55:54 AM
Michael W. Smith,1,2 Nick Patterson,3 James A. Lautenberger,1 Ann L. Truelove,1,2 Gavin J. McDonald,3,4 Alicja Waliszewska,3,5,6 Bailey D. Kessing,1,2 Michael J. Malasky,1,2 Charles Scafe,10 Ernest Le,3 Philip L. De Jager,3,5,6 Andre A. Mignault,4 Zeng Yi,11 Guy de The´,12 Myron Essex,7 Jean-Louis Sankale´,7 Jason H. Moore,13,14 Kwabena Poku,16 John P. Phair,17 James J. Goedert,18 David Vlahov,19 Scott M. Williams,13,14,15 Sarah A. Tishkoff,20 Cheryl A. Winkler,1,2 Francisco M. De La Vega,10 Trevor Woodage,10 John J. Sninsky,21 David A. Hafler,3,5,6 David Altshuler,3,4,8,9 Dennis A. Gilbert,10 Stephen J. O’Brien,1 and David Reich,3,4
1 Laboratory of Genomic Diversity, National Cancer Institute, and 2 Basic Research Program, Science Applications International Corporation, National Cancer Institute, Frederick, MD; 3 Program in Medical and Population Genetics, Broad Institute, Cambridge, MA; 4 Department of Genetics and 5 Laboratory of Molecular Immunology, Harvard Medical School, 6 Center for Neurologic Disease, Brigham and Women’s Hospital, 7 Harvard AIDS Institute and Department of Immunology and Infectious Diseases, Harvard School of Public Health, and Departments of 8 Medicine and 9 Molecular Biology, Massachusetts General Hospital, Boston; 10 Applied Biosystems, Foster City, CA; 11 Institute of Virology, Chinese Academy of Preventive Medicine, Beijing; 12 Department of Viral Oncology-Epidemiology, Institut Pasteur, Centre National de la Recherche Scientifique, Paris; 13 Department of Molecular Physiology and Biophysics, 14 Center for Human Genetics Research, and 15 Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University, Nashville, TN; 16 School of Administration, University of Ghana, Legon, Ghana; 17 Howard Brown Health Center and Department of Medicine, Northwestern University, Chicago; 18 Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD; 19 Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York; 20 Department of Biology, University of Maryland, College Park, MD; and 21 Celera Diagnostics, Alameda, CA
HAPPY 4th of July, INDEED!
Later,
W2P
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM